Sort   by:  
 Page size 
UnknownDisease progression in the first 5 years of treatment in multiple sclerosis: Predictive value of early brain and lesion volume changes.
Not available
S-EPMC10782656 | biostudies-literature
UnknownLow natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis.
Not available
S-EPMC12573372 | biostudies-literature
UnknownInsights into the accuracy of social scientists' forecasts of societal change.
Not available
S-EPMC10192018 | biostudies-literature
Sort   by:  
 Page size